Google
WGS — GENEDX HOLDINGS CORP. (Healthcare >> Diagnostics & Research)
WGS FAQ
What is WGS's P/E ratio?
GENEDX HOLDINGS CORP. (WGS) currently trades at a P/E ratio of 142.82.
What is WGS's ROE?
GENEDX HOLDINGS CORP. reports a Return on Equity (ROE) of -30.62%.
What is WGS's dividend yield?
GENEDX HOLDINGS CORP. offers a dividend yield of 0.00%.
What is WGS's Deepscope Quality Score?
Deepscope rates WGS's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy WGS?
Deepscope's AI Timing Score for WGS is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does WGS belong to?
GENEDX HOLDINGS CORP. is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 53.13
Price
1.13
(2.17%)
Day Change
|
|
|---|
WGS, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 92 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 53.13 |
| PBV / Sector |
6.07 / -23.82
|
| Earning Per Share | -2.68 |
| PE / Sector |
142.82 / 37.33
|
| PEG or PE/Growth / Sector |
-1.95 / 1.35
|
| Average 1M Daily Value |
86.50 M
|
| Average 1W Daily Value |
56.08 M
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-03 09:10:46 |
| Symbol | WGS |
| Name | GENEDX HOLDINGS CORP. |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 29.69 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,543.78 / 31,921.95 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: North Tower, Stamford, CT, United States, 06902
Phone: 888 729 1206
Website: https://www.genedx.com
Employees: 1,300
Description: GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
